Showing results (11-20 of 476) with videos related to
Sort By:
Pageof 48
The Biochemical Journal|June 15, 1995
Heat shock of human synovial and dermal fibroblasts induces delayed up-regulation of collagenase-gene expressionE G Hitraya, J Varga, S A JimenezAnnals of Internal Medicine|September 1, 1989
Systemic sclerosis after augmentation mammoplasty with silicone implantsJ Varga, H R Schumacher, S A JimenezArthritis and Rheumatism|January 1, 1992
Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestionJ Varga, G G Maul, S A JimenezBiochemical and Biophysical Research Communications|September 30, 1987
PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblastsJ Varga, A Diaz-Perez, J Rosenbloom, et al.The Journal of Rheumatology|February 1, 1991
Eosinophilic fasciitis is clinically distinguishable from the eosinophilia-myalgia syndrome and is not associated with L-tryptophan useJ Varga, R Griffin, J H Newman, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1994
L-Tryptophan in supraphysiologic concentrations stimulates collagenase gene expression in human skin fibroblastsJ Varga, L Li, A Mauviel, et al.Gene|July 17, 1998
Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitroS J Chen, C M Artlett, S A Jimenez, et al.Matrix Biology : Journal of the International Society for Matrix Biology|December 5, 1998
Modulation of basal expression of the human alpha1(I) procollagen gene (COL1A1) by tandem NF-1/Sp1 promoter elements in normal human dermal fibroblastsC M Artlett, S J Chen, J Varga, et al.The Journal of Investigative Dermatology|January 1, 1991
Elevated expression of the genes for transforming growth factor-beta 1 and type VI collagen in diffuse fasciitis associated with the eosinophilia-myalgia syndromeJ Peltonen, J Varga, S Sollberg, et al.The Journal of Rheumatology|July 24, 1998
A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung diseaseG Várai, L Earle, S A Jimenez, et al.Pageof 48